GEO Publications
Handout
NAR 2024 (latest)
NAR 2002 (original)
All publications
FAQ
MIAME
Email GEO
NCBI
>
GEO
>
Accession Display
Not logged in |
Login
GEO help:
Mouse over screen elements for information.
Scope:
Self
Platform
Samples
Series
Family
Format:
HTML
SOFT
MINiML
Amount:
Brief
Quick
GEO accession:
Sample GSM80779
Query DataSets for GSM80779
Status
Public on Mar 30, 2006
Title
oral_mucosa_4
Sample type
RNA
Source name
oral_mucosa
Organism
Homo sapiens
Characteristics
Normal tissue
Extracted molecule
total RNA
Extraction protocol
Total RNA extracted using standard Trizol protocol, followed by Qiagen RNeasy column clean-up
Label
biotin
Label protocol
Approximately 5 µg of total RNA was processed to produce biotinylated cRNA targets.
Hybridization protocol
standard Affymetrix procedures
Scan protocol
standard Affymetrix procedures
Description
oral_mucosa_4
Data processing
RMA
Submission date
Oct 28, 2005
Last update date
Aug 28, 2018
Contact name
Richard B Roth
E-mail(s)
rroth@neurocrine.com
Organization name
Neurocrine Biosciences, Inc.
Department
Molecular Medicine
Street address
12790 El Camino Real
City
San Diego
State/province
CA
ZIP/Postal code
92130
Country
USA
Platform ID
GPL570
Series (1)
GSE3526
Comparison of gene expression profiles across the normal human body
Relations
Reanalyzed by
GSE64985
Reanalyzed by
GSE119087
Data table header descriptions
ID_REF
Affymetrix U133 plus 2.0 array
VALUE
RMA
Data table
ID_REF
VALUE
1007_s_at
681.5244
1053_at
86.521255
117_at
249.18085
121_at
280.91028
1255_g_at
16.657782
1294_at
168.01135
1316_at
109.411194
1320_at
47.07721
1405_i_at
49.34156
1431_at
31.104794
1438_at
137.5509
1487_at
188.5259
1494_f_at
78.09257
1552256_a_at
176.69812
1552257_a_at
423.76865
1552258_at
42.51594
1552261_at
51.020054
1552263_at
37.964535
1552264_a_at
67.36175
1552266_at
23.10934
Total number of rows:
54613
Table truncated, full table size
1089 Kbytes
.
Supplementary file
Size
Download
File type/resource
GSM80779.CEL.gz
7.5 Mb
(ftp)
(http)
CEL
|
NLM
|
NIH
|
GEO Help
|
Disclaimer
|
Accessibility
|